You are here » Home » Companies » Company Overview » Glaxosmithkline Pharma Ltd

Glaxosmithkline Pharma Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE LIVE 15:40 | 23 Sep 2801.20 6.25
(0.22%)
OPEN

2800.05

HIGH

2822.00

LOW

2793.00

NSE LIVE 15:59 | 23 Sep 2805.25 10.40
(0.37%)
OPEN

2800.05

HIGH

2826.45

LOW

2793.35

OPEN 2800.05
PREVIOUS CLOSE 2794.95
VOLUME 2309
52-Week high 3850.00
52-Week low 2786.50
P/E 67.61
Mkt Cap.(Rs cr) 23726.16
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 2800.05
CLOSE 2794.95
VOLUME 2309
52-Week high 3850.00
52-Week low 2786.50
P/E 67.61
Mkt Cap.(Rs cr) 23726.16
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glaxosmithkline Pharma Ltd.

Glaxosmithkline Pharma Ltd

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives dermatology gynaecology diabetes oncology cardiovascular disease and respiratory diseases. They also offer a range of vaccine...> More

Glaxosmithkline Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   23,726
EPS - TTM () [*S] 41.43
P/E Ratio (X) [*S] 67.61
Face Value ()   10
Latest Dividend (%)   500.00
Latest Dividend Date 15 Jul 2016
Dividend Yield (%) 1.79
Book Value / Share () [*S] 202.73
P/B Ratio () [*S] 13.82
[*C] Consolidated     [*S] Standalone

Glaxosmithkline Pharma Ltd - Financial Results

Particulars ( cr) Jun 2016 Jun 2015 % Chg
Net Sales 705.33 651.7 8.23
Other Income 25.84 39.88 -35.21
Total Income 729.35 691.58 5.46
Total Expenses 614.98 542.96 13.26
Operating Profit 114.37 148.62 -23.05
Net Profit 72.27 94.01 -23.13
Equity Capital 84.7 84.7 -
> More on Glaxosmithkline Pharma Ltd Financials Results

Glaxosmithkline Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Piramal Enterp. 1908.15 0.95 32925.13
Torrent Pharma. 1640.00 -0.31 27752.08
Glenmark Pharma. 945.25 1.67 26674.95
Glaxosmit Pharma 2801.20 0.22 23726.16
Alkem Lab 1758.80 1.47 21026.45
Biocon 962.00 -0.13 19240.00
Ajanta Pharma 2041.75 -0.02 17967.40
> More on Glaxosmithkline Pharma Ltd Peer Group

Glaxosmithkline Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 8.01
FIIs 2.28
Insurance 0.00
Mutual Funds 1.71
Indian Public 11.93
Custodians 0.00
Other 1.07
> More on Glaxosmithkline Pharma Ltd Share Holding Pattern

Glaxosmithkline Pharma Ltd - Research Reports

Date Broker Action Price Report
02/11 Angel Broking Neutral 3295 PDF IconDetails
06/08 Angel Broking Neutral 3746 PDF IconDetails
> More on Glaxosmithkline Pharma Ltd Research Reports

Glaxosmithkline Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.36% -0.75% 0.24% 0.59%
1 Month -8.93% -8.98% 2.42% 2.30%
3 Month -17.83% -17.88% 6.17% 6.78%
6 Month -23.96% -24.09% 13.15% 14.45%
1 Year -16.24% -16.18% 11.02% 12.56%
3 Year 16.57% 17.21% 44.05% 49.95%

Glaxosmithkline Pharma Ltd - STOCK STRENGTH

Today's Low/High 2793.00
2822.00
Week Low/High 2786.50
2980.00
Month Low/High 2786.50
3343.00
YEAR Low/High 2786.50
3850.00
All TIME Low/High 25.75
3850.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard